Article Details
Retrieved on: 2024-03-28 20:07:14
Tags for this article:
Click the tags to see associated articles and topics
Summary
The biotech company Loyal, focusing on extending the healthy lifespan of dogs, announced a $45 million funding round supporting FDA-approved longevity drugs development, aligning with transhumanist ideals of life extension to aging populations, including pets like beagles.
Article found on: yahopet.co.kr
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here